Spontaneous superior sagittal sinus thrombosis secondary to type II heparin-induced thrombocytopenia presenting as an acute subarachnoid hemorrhage

Journal of Clinical Neuroscience

Volumn 14, Issue 9, 2007, Pages 890-895

  Fountas, Kostas N ^a   Faircloth, Laurie R ^a   Hope, Tom ^a   Grigorian, Arthur A ^a  

^a MEDICAL CENTER OF CENTRAL GEORGIA   (United States)

Author keywords

Heparin; Subarachnoid hemorrhage; Superior sagittal sinus; Thrombocytopenia; Thrombosis

Indexed keywords

HEPARIN;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CEREBRAL SINUS THROMBOSIS; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIALYSIS; FEMALE; GENERAL CONDITION DETERIORATION; GLASGOW COMA SCALE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; MEDICAL EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; SUPERIOR SAGITTAL SINUS; THROMBOCYTOPENIA;

BRAIN; FEMALE; HEPARIN; HUMANS; KIDNEY FAILURE, CHRONIC; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; RENAL DIALYSIS; SAGITTAL SINUS THROMBOSIS; THROMBOCYTOPENIA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34447633518     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2006.06.011     Document Type: Article

References (58)

1. Chicoine M., Cross D., and Dacey R.G. Venus sinus thrombosis. In: Wilkins R.H., and Rengachary S.S. (Eds). Neurosurgery. 2nd ed. vol II (1996), McGraw-Hill, New York 2142-2150
2. Southwick F.S., and Swartz M.N. Inflammatory thrombosis of major dural venous sinuses and cortical veins. In: Wilkins R.H., and Rengachary S.S. (Eds). Neurosurgery. 2nd ed. vol III (1996), McGraw-Hill, New York 3307-3311
3. Stam J. Cerebral venous and sinus thrombosis: Incidence and causes. Adv Neurol 92 (2003) 225-232
4. de Bruijn S.F., de Haan R.J., and Stam J. Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. For the Cerebral Venous Sinus Study Group. J Neurol Neurosurg Psychiatry 70 (2001) 105-108
5. Ferro J.M., Canhao P., Stam J., et al. Prognosis of cerebral vein and dural sinus thrombosis. Results of the international study on cerebral vein and dural sinus thrombosis (ISCVT). Stroke 35 (2004) 664-670
6. Masuhr F., and Mehraein S. Cerebral venous and sinus thrombosis: Patients with a fatal outcome during intravenous dose-adjusted heparin treatment. Neurocrit Care 1 (2004) 355-362
7. Mehraein S., Schmidtke K., Villringer A., et al. Heparin treatment in cerebral sinus and venous thrombosis: patients at risk of fatal outcome. Cerebrovasc Dis 15 (2003) 17-21
8. Calhoun B.C., and Hessler J.W. Heparin-associated antibody with pregnancy: Discussion of two cases. Am J Obstet Gynecol 156 (1987) 964-966
9. Funk S., Eichler P., Albrecht D., et al. Heparin-induced thrombocytopenia (HIT) in orthopedic patients: a prospective cohort trial comparing UFH and LMWH [abstract]. Ann Hematol 79 Suppl (2000) A92
10. Kyritsis A.P., Williams E.C., and Schutta H.S. Cerebral venous thrombosis due to heparin-induced thrombocytopenia. Stroke 21 (1990) 1503-1505
11. Nakamoto H., Shimada Y., Kanno T., et al. Role of platelet factor 4-heparin complex antibody (HIT antibody) in the pathogenesis of thrombotic episodes in patients on hemodialysis. Hemodial Int 9 (2005) S2-S7
12. Spitzer C., Mull M., Rohde V., et al. Non-traumatic cortical subarachnoid hemorrhage: diagnostic work-up and etiological background. Neuroradiol 47 (2005) 525-531
13. Sztajzel R., Coeytaux A., Dehdashti A.R., et al. Subarachnoid hemorrhage: a rare presentation of cerebral venous thrombosis. Headache 41 (2001) 889-892
14. Walenga J.M., Jeske W.P., and Messmore H.L. Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia. J Thromb Thrombolysis 10 (2000) S13-S20
15. Greinacher A., Farner B., Kroll H., et al. Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients. Thromb Haemost 94 (2005) 132-135
16. Ohman E.M., Granger C.B., Rice L., et al. Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. J Thromb Thrombolysis 19 (2005) 11-19
17. Warkentin T.E. Venous thromboembolism in heparin-induced thrombocytopenia. Curr Opin Pulm Med 6 (2000) 343-351
18. Menajovsky L.B. Heparin-induced thrombocytopenia: clinical manifestations and management strategies. Am J Med 118 Suppl.8A (2005) 21S-30S
19. Aster R.H. Heparin-independent activation of platelets by HIT antibodies: a clue to the etiology of delayed thrombocytopenia/thrombosis in patients given heparin?. J Thromb Haemost 3 (2005) 2166-2167
20. Kravitz M.S., and Shoenfeld Y. Thrombocytopenic conditions - autoimmunity and hypercoagulability: commonalities and differences in ITP, TTP, HIT, and APS. Am J Hematol 80 (2005) 232-242
21. Palomo I., Pereira J., Alarcon M., et al. Prevalence of heparin-induced antibodies in patients with chronic renal failure undergoing hemodialysis. J Clin Lab Anal 19 (2005) 189-195
22. Warkentin T.E., Chong B.H., and Greinacher A. Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost 79 (1998) 1-7
23. Li Z.Q., Liu W., Park K.S., et al. Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody. Blood 99 (2002) 1230-1236
24. Lubenow N., and Greinacher A. Management of patients with heparin-induced thrombocytopenia: Focus on recombinant hirudin. J Thromb Thrombolysis 10 Suppl.1 (2000) 47-57
25. Yamamoto S., Koide M., Matsuo M., et al. Heparin-induced thrombocytopenia in hemodialysis patients. Am J Kidney Dis 28 (1996) 82-85
26. Sitter T., Spannagl M., Banas B., et al. Prevalence of heparin-induced PF4-heparin antibodies in hemodialysis patients. Nephron 79 (1998) 245-246
27. Luzzatto G., Bertoli M., Cella G., et al. Platelet count, anti-heparin/platelet factor 4 antibodies and tissue factor pathway inhibitor plasma antigen level in chronic dialysis. Thromb Res 89 (1998) 115-122
28. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med 352 (2005) 1791-1798
29. Chang R., and Friedman D.P. Isolated cortical venous thrombosis presenting as subarachnoid hemorrhage: a report of three cases. Am J Neuroradiol 25 (2004) 1676-1679
30. de Bruijn S.F., Stam J., and Kappelle L.J. Thunderclap headache as first symptom of cerebral venous sinus thrombosis: CVST study group. Lancet 348 (1996) 1623-1625
31. Oppenheim C., Domigo V., Gauvrit J.Y., et al. Subarachnoid hemorrhage as the initial presentation of dural sinus thrombosis. Case report. Am J Neuroradiol 26 (2005) 614-617
32. Oshiro S., Motomura K., and Fukushima T. Systemic lupus erythematosus manifesting as subarachnoid hemorrhage induced by cortical venous thrombosis and followed by medial medullary infarction. No To Shinkei 55 (2003) 791-795
33. Ra C.S., Lui C.C., Liang C.L., et al. Superior sagittal sinus thrombosis induced by thyrotoxicosis: case report. J Neurosurg 94 (2001) 130-132
34. Sasaki A., Nagaseki Y., Kakizawa T., et al. Superior sagittal sinus thrombosis complicated with multiple aneurysms presenting as subarachnoid hemorrhage: case report. Neurol Med Chir (Tokyo) 31 (1991) 978-981
35. Szancer S. Acute cerebral venous occlusion manifested by spontaneous subarachnoid hemorrhage. Neurology 5 (1955) 675-677
36. Zakharov A.G., Saribekian A.S., and Sharifulin F.A. A spontaneous subarachnoid hemorrhage in a female patient with an acute thrombus of the lateral venous sinuses of the brain (a case report). Zh Vopr Neirokhir Im N N Burdenko 4 (1997) 29-32
37. Spencer F.A. Heparin-induced thrombocytopenia: Patient profiles and clinical manifestations. J Thromb Thrombolysis 10 (2000) S21-S25
38. Walenga J.M., Jeske W.P., Prechel M.M., et al. Decreased prevalence of heparin-induced thrombocytopenia with low-molecular-weight heparin and related drugs. Semin Thromb Hemost 30 Suppl.1 (2004) 69-80
39. Merz S., Fehr R., and Guike C. Sinus vein thrombosis. A rare complication of heparin-induced thrombocytopenia type II. Anaesthetist 53 (2004) 551-554
40. Warkentin T.E. History of heparin-induced thrombocytopenia. In: Warkentin T.E., and Greinacher A. (Eds). Heparin-Induced Thrombocytopenia (2000), Marcel Dekker, New York 1-15
41. Meyer-Lindenberg A., Quenzel E.M., Bierhoff E., et al. Fatal cerebral venous sinus thrombosis in heparin induced thrombotic thrombopenia. Eur Neurol 37 (1997) 191-192
42. Pohl C., Harbrecht U., Greinacher A., et al. Neurologic complications in immune-mediated heparin-induced thrombocytopenia. Neurol 54 (2000) 1240-1245
43. Van Der Weyden M.B., Hunt H., et al. Delayed-onset heparin-induced thrombocytopenia: A potentially malignant syndrome. Med J Aust 2 (1983) 132-135
44. Walther E.U., Tiecks F.P., and Haberl R.L. Cranial sinus thrombosis associated with essential thrombocythemia followed by heparin associated thrombocytopenia. Neurology 47 (1996) 300-301
45. Warkentin T.E., and Bernstein R.A. Delayed onset heparin-induced thrombocytopenia and cerebral thrombosis after a single administration of unfractionated heparin. N Engl J Med 348 (2003) 1067-1069
46. Amiral J., Bridey F., Dreyfus M., et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia [letter]. Thromb Haemost 68 (1992) 95-96
47. Kelton J.G., Sheridan D., Santos A., et al. Heparin-induced thrombocytopenia: laboratory studies. Blood 72 (1988) 925-930
48. Warkentin T.E., Hayward C.P., Boshkov L.K., et al. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 84 (1994) 3691-3699
49. Warkentin T.E., and Sheppard J.I. Generation of platelet-derived microparticles and procoagulant activity by heparin-induced thrombocytopenia lgG/serum and other lgG platelet agonists: a comparison with standard platelet agonists. Platelets 10 (1999) 319-326
50. Vidailhet M., Piette J.C., Wechsler B., et al. Cerebral venous thrombosis in systemic lupus erythematosus. Stroke 21 (1990) 1226-1231
51. Warkentin T.E., Levine M.N., Hirsh J., et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 332 (1995) 1330-1335
52. Warkentin T.E., and Kelton J.G. A 14-year study of heparin-induced thrombocytopenia. Am J Med 101 (1996) 502-507
53. Einhaupl K.M., Villringer A., Meister W., et al. Heparin treatment in sinus venous thrombosis. Lancet 338 (1991) 597-600
54. Chong B.H. Low molecular weight heparinoid and heparin-induced thrombocytopenia [abstract]. Aust N Z J Med 26 (1996) 331
55. Tardy-Poncet B., Tardy B., Reynaud J., et al. Efficacy and safety of danaparoid sodium (ORG 10172) in critically ill patients with heparin-associated thrombocytopenia. Chest 115 (1999) 1616-1620
56. Greinacher A., Farner B., Kroll H., et al. Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of two prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range. Blood 96 (2000) 846-851
57. Diaz J.M., Schiffman J.S., Urban E.S., et al. Superior sagittal sinus thrombosis and pulmonary embolism: a syndrome rediscovered. Acta Neurol Scand 86 (1992) 390-396
58. Canhao P., Falcao F., and Ferro J.M. Thrombolytics for cerebral sinus thrombosis: a systematic review. Cerebrovasc Dis 15 (2003) 159-166